Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin in Late-Stage Chronic Kidney Disease
NCT07027774Phase 4Not yet recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of henagliflozin in chronic kidney disease (CKD), sponsored by Yejishan Hospital of Wannan Medical College. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07027774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07027774.